Lument Finance Trust (NYSE:LFT – Get Free Report) was downgraded by stock analysts at Raymond James from an “outperform” rating to a “market perform” rating in a report issued on Thursday, MarketBeat.com reports.
Lument Finance Trust Stock Performance
LFT opened at $2.65 on Thursday. Lument Finance Trust has a 12-month low of $1.91 and a 12-month high of $2.75. The stock has a market cap of $138.48 million, a price-to-earnings ratio of 8.28 and a beta of 1.06. The business has a 50 day moving average of $2.53 and a 200-day moving average of $2.45. The company has a quick ratio of 5.78, a current ratio of 5.78 and a debt-to-equity ratio of 5.64.
Lument Finance Trust (NYSE:LFT – Get Free Report) last released its quarterly earnings data on Monday, August 12th. The technology company reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.02). Lument Finance Trust had a net margin of 16.91% and a return on equity of 14.10%. The business had revenue of $30.64 million during the quarter, compared to analyst estimates of $9.82 million. During the same period in the previous year, the business earned $0.04 earnings per share. On average, equities research analysts expect that Lument Finance Trust will post 0.42 earnings per share for the current year.
Institutional Trading of Lument Finance Trust
Lument Finance Trust Company Profile
Lument Finance Trust, Inc, a real estate investment trust, focuses on investing in, financing, and managing a portfolio of commercial real estate (CRE) debt investments in the United States. The company primarily invests in transitional floating rate CRE mortgage loans on middle market multi-family assets; and other CRE -related investments, including mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed rate loans, construction loans, and other CRE debt instruments.
Featured Articles
- Five stocks we like better than Lument Finance Trust
- The 3 Best Blue-Chip Stocks to Buy Now
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Top Biotech Stocks: Exploring Innovation Opportunities
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- What Are Dividend Champions? How to Invest in the Champions
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Lument Finance Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lument Finance Trust and related companies with MarketBeat.com's FREE daily email newsletter.